Summary |
|
|||||||||||||
Variant origin |
|
|||||||||||||
Variant description |
|
|||||||||||||
Phenotypes |
View phenotypes and curated references for all genotypes (concatenated display).
|
|||||||||||||
Expression |
|
|||||||||||||
Notes |
Ath11 fits either a dominant or additive mode of inheritance.
Candidate Genes
Tnfaip3 was identified and investigated as a candidate gene for the QTL Ath11 on mouse Chromosome 10. No differences in Tnfaip3 expression level was found between parental strains FVB/N and C57BL/6J. However, sequence analysis revealed a Glu627Ala amino acid substitution between C57BL/6J and FVB/N, respectively. This functional polymorphism is thought to result in increased Nfkb inhibition in FVB/N compared to C57BL/6J.
Mapping and Phenotype information for this QTL, its variants and associated markersJ:76127Two independent strain intercosses that carry atherosclerosis phenotype-sensitizing Apoe deficiency were performed to reveal artherosclerosis susceptibility loci that are distinct from loci linked to lipoprotein levels. Animals from a C57BL/6J-derived background are susceptible to atherosclerosis and yield several-fold higher aortic lesion scores compared to animals from an FVB/NCr-derived background.In the first cross, referred to as cross 1, B6.129P2-Apoetm1Unc x FVB.129P2-Apoetm1Bres F1 mice were crossed and the F1 offspring were intercrossed to create 197 (B6.129P2-Apoetm1Unc x FVB.129P2-Apoetm1Bres) F2 mice for the QTL analysis. Interval mapping was done with 194 markers at a distance of no more than 10cM. In the second, confirmatory cross, B6.129P2-Apoetm1Unc x FVB.129P2-Apoetm1Bres F1 mice were crossed and the F1 offspring were intercrossed to create 186 (B6.129P2-Apoetm1Unc x FVB.129P2-Apoetm1Bres)F2 mice for QTL analysis. This cross was referred to as cross 2; these mice were genotyped using 127 markers at no more than 10cM intervals.A highly significant locus on chromosome 10 was identified in both crosses with a LOD score of 7.8 at D10Mit213 in cross 1 and 11.9 at D10Mit214 in cross 2. The locus accounted for 19% of log lesion variance in cross 1 and 25% in cross 2. Interval mapping of chromosome 10 in cross 1 revealed a peak that included both D10Mit13 and D10Mit14. The locus was labeled Ath11.Highly significant LOD scores were obtained using either a dominant or additive model. Unexpectedly, in cross one, homozygosity for FVB/NCr-derived alleles conferred increased lesion size when compared to mice heterozygous or homozygous for the C57BL/J allele.The strongest candidate gene for Ath11 is Ifngr, which is located at 15cM on mouse chromosome 10. Ath11 maps to an interval (0-19cM) that is evolutionarily conserved with human chromosome 6q22-24. |
|||||||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|